Ohr Pharmaceutical Inc Human Resources Contracts & Agreements
26 Contracts & Agreements
- Bonus & Incentive Agreements (7 contracts)
- Compensation Agreements (3)
- Consulting Agreements (2)
- Employment Agreements (12)
- Separation Agreements (2)
- Amendment No. 1 to NeuBase Therapeutics, Inc. 2019 Stock Incentive Plan (Filed With SEC on July 31, 2023)
- Outside Director Compensation Policy (Filed With SEC on September 12, 2022)
- Offer Letter of Employment, effective January 10, 2022, by and between NeuBase Therapeutics, Inc. and Todd Branning (Filed With SEC on January 10, 2022)
- Separation Agreement and General Release, dated September 30, 2021, by and between Sam Backenroth and NeuBase Therapeutics, Inc (Filed With SEC on October 1, 2021)
- Offer Letter of Employment, dated May 17, 2021, by and between NeuBase Therapeutics, Inc. and Kia Motesharei (Filed With SEC on May 25, 2021)
- Offer Letter of Employment, effective May 17, 2021, by and between NeuBase Therapeutics, Inc. and Sandra Rojas-Caro (Filed With SEC on May 20, 2021)
- Offer Letter of Employment, dated November 30, 2020, by and between NeuBase Therapeutics, Inc. and Curt Bradshaw (Filed With SEC on December 2, 2020)
- Outside Director Compensation Policy (Filed With SEC on September 11, 2020)
- Offer Letter of Employment, dated July 22, 2020, by and between NeuBase Therapeutics, Inc. and William Mann (Filed With SEC on July 28, 2020)
- Offer of Employment, dated July 11, 2019, by and between NeuBase Therapeutics, Inc. and Dietrich A. Stephan (Filed With SEC on July 17, 2019)
- Form of Option Agreement under NeuBase Therapeutics, Inc. 2018 Equity Incentive Plan (Filed With SEC on March 8, 2019)
- NeuBase Therapeutics, Inc. 2018 Equity Incentive Plan (Filed With SEC on March 8, 2019)
- Retention Bonus Agreement, by and between Ohr Pharmaceutical, Inc. and Dr. Jason Slakter (Filed With SEC on January 3, 2019)
- Separation Agreement, dated as of May 12, 2017, between Ohr Pharmaceutical, Inc. and Ira Greenstein (Filed With SEC on May 12, 2017)
- Amendment to The 2014 Stock Incentive Plan (Filed With SEC on December 14, 2015)
- Consulting Agreement and Release, dated December 11, 2015, between Ohr Pharmaceutical, Inc. and Irach B. Taraporewala (Filed With SEC on December 14, 2015)
- 2014 Stock Incentive Plan, as amended (Filed With SEC on March 13, 2015)
- Amendment, dated January 6, 2015, to Backenroth employment agreement (Filed With SEC on January 8, 2015)
- Amendment, dated January 6, 2015, to Taraporewala employment agreement (Filed With SEC on January 8, 2015)
- 2014 Stock Incentive Plan (Filed With SEC on April 14, 2014)
- Employment Agreement with Mr. Backenroth, dated January 8, 2014 (Filed With SEC on January 10, 2014)
- Employment Agreement with Dr. Taraporewala, dated January 8, 2014 (Filed With SEC on January 10, 2014)
- Employment Agreement with Sam Backenroth, dated August 9, 2013 (Filed With SEC on August 13, 2013)
- Employment Agreement with Irach Taraporewala, dated August 9, 2013 (Filed With SEC on August 13, 2013)
- Compensation Committee Charter Adopted on June 13, 2013 (Filed With SEC on June 19, 2013)
- CONSULTING AGREEMENT (Filed With SEC on November 12, 2008)
